PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för dicoumarol. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

7 hits

Bibliografisk träff 2017-02-06

Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.

Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY, Meehan BS, Pediongco T, Birkinshaw RW, Chen Z, Wang H, D'Souza C, Kjer-Nielsen L, Gherardin NA, Godfrey DI, Kostenko L, Corbett AJ, Purcell AW, Fairlie DP, McCluskey J, Rossjohn J.

Nat Immunol · research support, non-u.s. gov't; journal article · DOI 10.1038/ni.3679

Bibliografisk träff 2010-05-01

Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.

Buranrat B, Prawan A, Kukongviriyapan U, Kongpetch S, Kukongviriyapan V.

World J Gastroenterol · research support, non-u.s. gov't; research-article; journal article · DOI 10.3748/wjg.v16.i19.2362

Bibliografisk träff 2009-07-06

Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation.

Matsui Y, Watanabe J, Ding S, Nishizawa K, Kajita Y, Ichioka K, Saito R, Kobayashi T, Ogawa O, Nishiyama H.

BJU Int · journal article · DOI 10.1111/j.1464-410x.2009.08732.x

Bibliografisk träff 2008-03-01

Dicoumarol down-regulates human PTTG1/Securin mRNA expression through inhibition of Hsp90.

Hernández A, López-Lluch G, Bernal JA, Navas P, Pintor-Toro JA.

Mol Cancer Ther · research support, non-u.s. gov't; journal article · DOI 10.1158/1535-7163.mct-07-0457

Bibliografisk träff 2006-05-01

The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.

Asher G, Dym O, Tsvetkov P, Adler J, Shaul Y.

Biochemistry · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1021/bi0600087

Bibliografisk träff 2005-02-01

Dicumarol is a potent reversible inhibitor of gap junctional intercellular communication.

Abdelmohsen K, Stuhlmann D, Daubrawa F, Klotz LO.

Arch Biochem Biophys · research support, non-u.s. gov't; journal article · DOI 10.1016/j.abb.2004.11.002

Bibliografisk träff 1967-04-01

The biosynthesis of dicoumarol.

Bellis DM, Spring MS, Stoker JR.

Biochem J · research-article; journal article · DOI 10.1042/bj1030202